Kinetic Study of Human Full-Length Wild-Type JAK2 and V617F Mutant Proteins

The Open Enzyme Inhibition Journal
doi 10.2174/1874940200801010080
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

JAK2-V617F-mediated Signalling Is Dependent on Lipid Rafts and Statins Inhibit JAK2-V617F-dependent Cell Growth

British Journal of Haematology
Hematology
2012English

Degradation of Overexpressed Wild-Type and Mutant Uricase Proteins in Cultured Cells

Journal of Histochemistry and Cytochemistry
AnatomyHistology
1999English

Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Hsp90 Prevents Interaction Between CHIP and HERG Proteins to Facilitate Maturation of Wild-Type and Mutant HERG Proteins

Cardiovascular Research
Cardiovascular MedicinePhysiologyCardiology
2013English

Screening of JAK2 V617F Mutation in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Kronik Miyeloproliferatif Hastalık Olgularında JAK2 V617F Mutasyon Sıklığı

Harran Üniversitesi Tıp Fakültesi Dergisi
2019English

Intracellular Transport, Assembly, and Degradation of Wild-Type and Disease-Linked Mutant Gap Junction Proteins

Journal of the Peripheral Nervous System
MedicineNeuroscienceNeurology
2001English

JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Prephenate Dehydratase of the actinomyceteAmycolatopsis Methanolica: Purification and Characterization of Wild-Type and Deregulated Mutant Proteins

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy